Search for: "Gedeon v. Gedeon" Results 21 - 30 of 30
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2010, 1:41 pm by dnt.atheniense@gmail.com
Melhorar a comunicação com os públicos externo e interno é uma das metas estabelecidas pela atual gestão do desembargador Jamil Gedeon. [read post]
25 Jan 2017, 10:48 pm
  In Richter Gedeon v Generics [2016] EWCA Civ 410, Sir Robin Jacob upheld Sales J’s finding that such routine steps might include asking the author of a piece of prior art for clarification:  “I cannot see a logical distinction between a case where it is obvious to look something up and one where it is obvious to ask and clear that the answer would be given and would be clear. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
3 Oct 2011, 5:20 am
 Having briefly summarised Ranbaxy v AstraZeneca, Datacard Corporation v Eagle and Gedeon Richter v Bayer Schering Pharma AG, Mr Alexander stressed that the prior art status of commonly accessible documents marked confidential in LG Electronics v Sony was yet to be conclusively determined – "watch this space". [read post]
15 Jan 2024, 3:16 am by Miquel Montañá (Clifford Chance)
However, the FMC had doubts as to whether this strict liability standard was in line with article 9(7) of Directive 2004/48/EC, as interpreted by the CJEU in its judgment of 12 September 2019 (case C-688/17 Bayer Pharma and Richter Gedeon). [read post]
6 Oct 2014, 5:43 am
As Justice Holmes stated in Crowley v Pulsifer (137 Mass 392 [1884]): It is desirable that the trial of cases should take place under public eye, not because the controversies of one citizen are of public concern, but because it is of the highest moment that those who administer [read post]
17 May 2021, 12:45 am by Annsley Merelle Ward
  Biogen and Samsung Bioepis / Richter Gedeon Nyrt, District Court of The Hague 29 August 2020 (Judges Kokke, Knijff and Schüller) [Dutch decision here]In a case between pharmaceutical companies Biogen c.s. and Richter, the District Court of The Hague considered how an auxiliary request filed by Richter with proceedings pending affects the invalidity discussion. [read post]